Vitamin D: Non-skeletal actions and effects on growth

Nutrition Research

Volumn 19, Issue 11, 1999, Pages 1683-1718

  Lal, Harbans ^a   Pandey, Rajesh ^a   Aggarwal, S K ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Calcitriol; Deltanoids; Growth; Non skeletal actions; Vitamin D; Vitamin D receptors

Indexed keywords

CALCITRIOL; GROWTH HORMONE; INSULIN; VITAMIN D;

ANTINEOPLASTIC ACTIVITY; BONE GROWTH; CANCER INHIBITION; DRUG EFFECT; DRUG MECHANISM; ENDOCRINE DISEASE; HORMONE RELEASE; IMMUNOMODULATION; OSTEOPOROSIS; PRIORITY JOURNAL; PSORIASIS; REGULATORY MECHANISM; REVIEW;

EID: 0033230473     PISSN: 02715317     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0271-5317(99)00124-4     Document Type: Review

References (195)

1. Endres DB, Rude RK. Mineral and bone metabolism. In: Burtis CA, Ashwood ER, eds. Tietz Textbook of Clinical Chemistry, 2nd Ed. Philadelphia :W.B. Saunders, 1994: 1887-973.
2. 3 in Tilapia mossambica: Relevance of photochemical synthesis. J Nutr Sci Vitaminol 1997; 43: 425-33.
3. Kinyamu HK, Gallagher JC, Rafferty KA, Balhorn KE. Dietary calcium and vitamin D intake in elderly women: Effect on serum parathyroid hormone and vitamin D metabolites. Am J Clin Nutr 1998; 67: 342-8.
4. Park K. Nutrition and health. In: Park's Textbook of Preventive and Social Medicine, 15th Ed. Jabalpur: Banarsidas Bhanot, 1997: 392-438.
5. 3 and its metabolites in the tomato plant. Phytochemistry 1996; 42: 617-20
6. Holick MF. Sunlight, vitamin D and human health. In: Holick MF, Jung EG, eds. Proceedings, Symposium on the Biological Effects of Light. Berlin: Walter de Gruyter and Co., 1994: 3-15.
7. Glew RH. Lipid metabolism II: Pathways of metabolism of special lipids. In: Devlin TM, ed. Textbook of Biochemistry with Clinical Correlations, 4th Ed. New York : Wiley-Liss, 1997: 395-443.
8. 3. Science 1981; 211: 590-3.
9. 3 by causing its photodegradation. J Clin Endocrinol Metab 1989; 68: 882-7.
10. 3. J Biol Chem 1986; 256: 9389-91.
11. Holick MF. Environmental factors that influence the cutaneous production of vitamin D. Am J Clin Nutr 1995; 61(Suppl): 638S-45S.
12. 3 synthesis. J Clin Endocrinol Metab 1987; 64: 1165-8.
13. 3. J Clin Endocrinol Metab 1992; 75: 1099-103
14. 3 synthesis in human skin. J Clin Endocrinol Metab 1988; 67: 373-8.
15. 3. Lancet 1982; I: 74-6.
16. 3. J Clin Invest 1985; 76: 1536-8.
17. Tan CY, Strathum B, Marks R. Skin thickness measurement by pulsed ultrasound: Its reproducibility, validation and variability. Br J Dermatol 1982; 106: 657-67.
18. Haddad JG Jr. Transport of vitamin D metabolites. Clin Orthop 1979; 142: 249-61.
19. Henry HL, Norman AW. Vitamin D: Metabolism and biological actions. Ann Rev Nutr 1984; 4: 493-520.
20. Reichel H, Koeffler HP, Norman AW. The role of the vitamin D endocrine system in health and disease. N Engl J Med 1989; 320: 980-91.
21. Kumar R. Vitamin D metabolism and mechanism of calcium transport. J Am Soc Nephrol 1990; 1: 30-42.
22. 3 blunts parathyroid hormone induction of kidney 1-hydroxylase. Arch Biochem Biophys 1995; 319: 535-9.
23. Granner DK. Hormones that regulate calcium metabolism. In: Murrary RK, Granner DK, Mayes PA, Rodwell VW, eds. Harper's Biochemistry, 24th Ed. London : Prentice-Hall International, 1996; 539-46
24. Norman AW, Roth J, Orci L. The vitamin D endocrine system: Steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocr Rev 1982; 3: 331-66.
25. Chen KS, DeLuca HF. Cloning of the human 1 alpha, 25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and iden- tification of two vitamin D-responsive elements. Biochim Biophys Acta 1995; 1263 : 1-9.
26. Zierold C, Darwish HM, DeLuca HF. Two vitamin D response elements function in the rat 1,25-dihydroxyvitamin D 24-hydroxylase promoter. J Biol Chem 1995; 270: 1675-8.
27. 3 and calcitriol administration in vitro. J Bone Miner Res 1995; 10: 1148-57.
28. Norman AW. Sunlight, season, skin pigmentation, vitamin D, and 25-hydroxyvitamin D: Integral components of the vitamin D endocrine system. Am J Clin Nutr 1998; 67: 1108-10.
29. Weaver VM, Franks DJ, Welsh JE. Activation of protein kinase C modulates dihydroxycholecalciferol synthesis in rat renal tubules . Cell Signal 1992; 4: 293-301.
30. 3 by phosphorylation of ferredoxin. Biochem J 1990; 266: 385-92.
31. Singh KP, Dash RJ. Vitamin D endocrine system. J Assoc Physicians India 1997; 45: 559-68.
32. 3 by human placenta in vitro. J Clin Endocrinol Metab 1981; 53: 484-8.
33. Dusso A, Brown A, Slatopolsky E. Extrarenal production of calcitriol. Semin Nephrol 1994; 14: 144-55.
34. Gkonos PJ, London R, Hendler ED. Hypercalcemia and elevated 1,25-dihydroxyvitamin D levels in a patient with end stage renal disease and active tuberculosis. N Engl J Med 1984; 311: 1683-5.
35. 3 levels in Hodgkin's disease. Am J Med 1988; 84: 165-8.
36. Zaloga GP, Eil G, Medbery CA. Humoral hypercalcemia in Hodgkin's disease. Arch Intern Med 1985; 145: 155-7.
37. 3 in three patients with lymphoma-associated hypercalcemia. J Clin Endocrinol Metab 1985; 60: 29-33.
38. Holick MF. Vitamin D and the kidney . Kidney Int 1987; 32: 912-29.
39. 3 in human monocytes and macrophages: A mechanism for the hypercalcemia of various granulomatoses. J Clin Endocrinol Metab 1997; 82: 2222-32.
40. 3, a steroid hormone that produces biological effects via both genomic and nongenomic pathways. J Steroid Biochem Mol Biol 1992; 41: 231-40.
41. Haussler MR, Jurutka PW, Hsieh JC, Thompson PD, Selznick SH, Haussler CA, Whitfield GK. New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone. Bone 1995; 17(Suppl) : 33S-8S.
42. Blanco JCG, Wang IM, Tsai SY, Tsai MJ, O'Malley BW, Jurutka PW, Hausslar MR, Ozats K. Transcription factor TFIIB and the vitamin D receptor cooperatively activate ligand-dependent transcription. Proc Natl Acad Sci USA 1995; 92: 1535-9.
43. Munder M, Herzberg IM, Zierold C, Moss, Hanson R, Clagett-Dame M, DeLuca HF. Identification of the porcine intestinal accessory factor that enables DNA sequence recognition by vitamin D receptor. Proc Natl Acad Sci USA 1995; 92: 2795-9.
44. MacDonald PN, Sherman DR, Dowd DR, Jefcoat SC, Jr, DeLisle RK. The vitamin D receptor interacts with general transcription factor IIB. J Biol Chem 1995; 270: 4748-52.
45. Patel SR, Xu Y, Koenig RJ, Hsu CH. Effect of glyoxylate on the function of the calcitriol receptor and vitamin D metabolism. Kidney Int 1997; 52: 39-44.
46. 3 metabolism. Kidney Int 1997; 52: 79-86.
47. 3 endocrine system. Endocr Rev 1995; 16: 200-57.
48. 3. J Biol Chem 1995; 270: 6639-43.
49. 3. Biochem J 1996; 316: 361-71.
50. Anzano MA, Smith JM, Uskokovic MR, Peer CW, Mullen LT, Letterio JJ, Welsh MC, Shrader MW, Logsdon DL, Driver CL, Brown CC, Roberts AB, Sporn MB. 1 α,25-dihydroxy- 16- ene- 23- yne-26,27-hexafluorochole-calciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res 1994; 54: 1653-6.
51. Bikle DD. Clinical counterpoint: Vitamin D: New actions, new analogs, new therapeutic potential. Endocr Rev 1992; 13: 756-8.
52. Chodynski M, Wojeiechowska W, Halkes SJ, van de Velde JP, Kutner A. Synthesis and in vitro evaluation of side chain unsaturated analogs of 24a, 24b-dihomo-1,25-dihydroxycholecalciferol. Steroids 1997; 62: 546-53.
53. Nishii Y, Fukushima M. History of vitamin D treatment of renal osteodystrophy. Am J Nephrol 1997; 17: 382-6.
54. 3. Endocrinology 1995; 136: 20-6.
55. Norman AW. Intestinal calcium absorption: A vitamin D-hormone-mediated adaptive response. Am J Clin Nutr 1990; 51: 290-300.
56. Dunn MA, Too SL, Ishizaki AS. Characterization of a novel protein in chick intestine that exhibits calcium-binding activity and regulation by dietary calcium, aluminium and vitamin D.J Nutr 1995; 125: 1916-24.
57. Duflos C, Bellaton C, Baghdassarian N, Gadoux M, Pansu D, Bronner F. 1,25-dihydroxycholecalciferal regulates rat intestinal calbindin D9K post-transcriptionally. J Nutr 1996; 126: 834-41.
58. Wasserman RH, Smith CA, Brindak ME, DeTalamoni N, Fullmer CS, Penniston JT, Kumar R. Vitamin D and mineral deficiencies increase the plasma membrane calcium pump of chicken intestine. Gastroenterology 1992; 102: 886-94.
59. 3 24-hydroxylase): Implications for differing mechanisms of regulation and involvement of multiple factors. Endocrinology 1995; 136: 3971-82.
60. Biehl RR, Baker DH, DeLuca HF. 1 alpha-hydroxylated cholecalciferol compounds act additively with microbial phytase to improve phosphorus, zinc and manganese utilization in chicks fed soy-based diets. J Nutr 1995; 125: 2407-16.
61. Dunn MA, Johnson NE, Liew MYB, Ross E. Dietary aluminium chloride reduces the amount of intestinal calbindin D-28K in chicks fed low calcium or low phosphorus diets. J Nutr 1993; 123: 1786-93.
62. Iacopino AM, Christakos S. Specific reduction of calcium-binding protein (28- kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc Natl Acad Sci USA 1990; 87: 4078-82.
63. 3. J Biol Chem 1988; 263: 2203-8.
64. 3 in the parathyroid glands of patients with renal failure. N Engl J Med 1987; 326: 1573-7.
65. Cohn DV, Fasciotto BH, Reese BK, Zhang JX. Chromogranin A: A novel regulation of parathyroid gland secretion. J Nutr 1995; 125 (Suppl): 2015S-9S.
66. Naveh-Many T, Silver J. Regulation of calcitonin gene transcription by vitamin D metabolites in vivo in the rat. J Clin Invest 1988; 81: 270-3.
67. Kumar V, Cotran RS, Robbins SL. Environmental diseases. In: Kumar V, Cotran RS, Robbins SL, eds. Basic Pathology, 6th Ed., Philadelphia: W.B. Saunders, 1997: 221-62.
68. 3 and parathyroid hormone. Biochim Biophys Acta 1996; 1312: 54-62.
69. 3. Endocrinology 1990; 126: 2088-94.
70. 3 causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow. Proc Natl Acad Sci USA 1985; 82: 8213-7.
71. 3 stimulates rat osteoblastic cells to release a soluble factor that increases osteoclastic bone resorption. J Clin Invest 1987; 80: 425-9.
72. 3 in the myeloid cell differentiation. Proc Soc Exp Biol Med 1989; 191: 214-20.
73. Kaplan FS. Prevention and Management of Osteoporosis (Clinical Symposia). New Jersey: Ciba-Geigy, 1995; 47: 1-32.
74. Krane SM, Holick MF. Metabolic bone disease. In: Fauci AS, Braunwald E, Isselbacker KJ, Wilson JD, Martin JB, Kasper DL, Hauser SL, Longo DL eds., Harrison's Principles of Internal Medicine, 14th Ed., Vol.2. New York : McGraw-Hill, 1998: 2247-59.
75. 3 receptor level in cultured human osteoblasts. Endocrinology 1996; 137: 1860-9.
76. Morrison NA, Yeoman R, Kelly PJ, Eisman JA. Contribution of transacting factor alleles to normal physiological variability : Vitamin D receptor gene polymorphisms and circulating osteocalcin. Proc Natl Acad Sci USA 1992; 89: 6665-9.
77. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofts L, Nguyen TV, Sambrook PN, Eisman JA. Prediction of bone density from vitamin D receptor alleles. Nature 1994; 367: 284-7.
78. Garton M, Martin J, New S, Lee S, Loveridge N, Milne J, Reid D, Reid I, Robins S. Bone mass and metabolism in women aged 45-55. Clin Endocrinol 1996; 44: 563-70.
79. Gallagher JC, Riggs BL, DeLuca HF. Effect of estrogen on calcium absorption and serum vitamin D metabolites in postmenopausal osteoporosis. J Clin Endocrinol Metab 1980; 51: 1359-64.
80. Riggs BL, Melton LJ III. Involutional osteoporosis. N Engl J Med 1986; 314: 1676-86.
81. Slovik DM, Adams JS, Neer RM, Holick MF, Potts JT. Deficient production of 1,25-dihydroxyvitamin D in elderly osteoporotic patients. N Engl J Med 1981; 305: 372-4.
82. 3 in chick kidney and pancreas. Biochem Biophys Res Commun 1979; 89: 56-63.
83. Schedl HP, Christensen KK, Ronnenberg WC. Effects of diabetes on calcium uptake by rat brush border membrane vesicles. Clin Exp Pharmacol Physiol 1995; 22: 272-6.
84. Raghunath M and Raghuramulu N. Diabetes mellitus and vitamin D. In: Nutrition News. Hyderabad : National Institute of Nutrition, 1992; 13: 1-3.
85. Ozono K, Seino Y, Yano H, Yamaoka K, Seino Y. 1,25- Dihydroxyvitamin D3 enhances the effect of refeeding on steady state preproinsulin messenger ribonucleic acid levels in rats. Endocrinology 1990; 126: 2041-5.
86. 3 on insulin secretion: Direct or mediated? Endocrinology 1986; 118: 1971-6.
87. Beaulieu C, Kestekian R, Harvankova J, Gascon-Barre M. Calcium is essential in normalizing intolerance to glucose that accompanies vitamin D depletion in vivo. Diabetes 1993; 42: 35-43.
88. Ghertow BS, Sivitz WI, Baranetsky NG, Clark SA, Waite A, DeLuca HF. Cellular mechanisms of insulin release: The effects of vitamin D deficiency and repletion on rat insulin secretion. Endocrinology 1983; 113: 1511-8.
89. 3 of insulin secretion and glucose tolerance in the vitamin D-deficient rat. Endocrinology 1987; 120: 1490-7.
90. Boucher BJ, Mannan N, Noonan K, Hales CN, Evans SJW. Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians. Diabetologia 1995; 38: 1239-45.
91. 3. J Endocrinol 1996; 148: 223-32.
92. Kautzky-Willer A, Pacini G, Barnas U, Ludvik B, Streli C, Graf H, Prager R. Intravenous calcitriol normalizes insulin sensitivity in uremic patients. Kidney Int 1995; 47: 200-6.
93. Druml W, Schwarzenhofer M, Apsner R, Horl WH. Fat-soluble vitamins in patients with acute renal failure. Mineral and Electrolyte Metab 1998; 24: 220-6.
94. 1 cells: Effects of pretreatment with 1,25-dihydroxycholecalciferol. Endocrinology 1990; 126: 2068-78.
95. 1) cells. J Endocrinol 1988; 117: 293-8.
96. 2+, dihydropyridines and ionomycin. J Endocrinol 1989; 121: 441-50.
97. Walters MR. Newly identified actions of the vitamin D endocrine system. Endocr Rev 1992; 13: 719-64.
98. 3-enhanced thyrotrophin secretion by rat pituitary cells in vitro. J Endocrinol 1989; 121:451-8.
99. Manolagas SC, Yu XP, Girasole G, Bellido T. Vitamin D and the hematolymphopoietic tissue: A 1994 update. Sem Nephrol 1994; 14: 129-43.
100. 3. Endocrinology 1993; 133: 553-62.
101. Hewison M. Vitamin D and the immune system (commentary). J Endocrinol 1992; 132: 173-5.
102. 3 in the myeloid cell differentiation. Proc Soc Exp Biol Med 1989; 191: 214-20.
103. 3-binding protein leads to immunosuppression in cancer patients. Cancer Res 1996; 56: 2827-31.
104. 3 suppresses proliferation and immunoglobulin production by normal human peripheral blood mononuclear cells. J Clin Invest 1984; 74: 657-61.
105. 3. J Clin Invest 1987; 79: 1659-64.
106. Johnsson C, Binderup L, Tufveson G. The effects of combined treatment with the novel vitamin D MC1288 and cyclosporine A on cardiac allograft survival. Transpl Immunol 1995; 3: 245-50.
107. 3 receptors and activities in muscles. J Biol Chem 1985; 260: 8882-91.
108. 3 stimulates Ca-ATPase in a vascular smooth muscle cell line. Biochem Biophys Res Commun 1988; 150: 1138-43.
109. 3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989; 83: 1903-15.
110. 2+-uptake by cultured vascular smooth muscle cells derived from rat aorta. Biochem Biophys Res Commun 1988; 152: 1388-94.
111. 45Ca uptake in vascular myocytes cultured from spontaneously hypertensive and normotensive rats. Life Sci 1991; 49: 651-9.
112. Oshima T, Young EW. Systemic and cellular calcium metabolism and hypertension. Sem Nephrol 1995; 15: 496-503.
113. Bukoshi RD, Ishibashi K, Bian K. Vascular actions of the calcium-regulating hormones. Sem Nephrol 1995; 15: 536-49.
114. Hojo M, August P. Calcium metabolism in normal and hypertensive pregnancy. Sem Nephrol 1995; 15: 504-11.
115. Marya RK, Rathee S, Manrow M. Effect of calcium and vitamin D supplementation on toxemia of pregnancy. Gynecol Obstet Invest 1987; 24: 38-42.
116. Kwiecinski GG, Petric GI, DeLuca HF. Vitamin D is necessary for reproductive function of the male rat. J Nutr 1989; 119: 741-4.
117. 3 receptors in the seminiferous tubules of the rat testis increase at puberty. Endocrinology 1984; 114: 2167-74.
118. 3. Cell Tissue Res 1987; 247: 453-5.
119. 3 in the human testis. J Steroid Biochem Mol Biol 1990; 35: 195-9.
120. Halloran BP. Is 1,25-Dihydroxyvitiamin D required for reproduction? Proc Soc Exp Biol Med 1989; 191: 227-32.
121. Sood S, Marya RK, Reghunandanan R, Singh GP, Jaiswal TS, Gopinathan K. Effect of vitamin D deficiency in testicular function in the rat. Ann Nutr Metab 1992; 36: 203-8.
122. Sood S, Reghunandanan R, Reghunandanan V, Marya RK, Singh PI. Effect of vitamin D repletion on testicular function in vitamin D-deficient rats. Ann Nutr Metab 1995; 39: 95-8.
123. Stumpf WE, Privette TH. The steroid hormone of sunlight soltriol (vitamin D) as a seasonal regulator of biological activities and photoperiodic rhythms. J Steroid Biochem Mol Biol 1991; 39: 283-9
124. Uhland-Smith A, DeLuca HF. 1,25-Dihydroxycholecalciferol analogs cannot replace vitamin D in normocalcemic male rats J Nutr 1993; 123: 1777-85.
125. Marya RK, Saini AS, Jaiswal TS. Effect of vitamin D supplementation during pregnancy on the neonatal skeletal growth in the rat. Ann Nutr Metab 1991; 35: 208-12.
126. Kato Y, Shimazu A, Iwamoto M, Nakashima K, Kieke T, Suzuki F, Nishii Y, Sato K. Role of 1,25-dihydroxycholecalciferol in growth plate cartilage: Inhibition of terminal differentiation of chondrocytes in vitro and in vivo. Proc Natl Acad Sci USA 1990; 87: 6522-6.
127. Stahl W, Nicolai S, Hanusch M, Sies H. Vitamin D influences gap junctional communication in C3H/1OT 1/2 murine fibroblast cells. FEBS Lett 1994; 352: 1-3.
128. Clairmont A, Tessmann D, Stock A, Nicolai S, Stahl W, Sies H. Induction of gap junctional intercellular communication by vitamin D in human skin fibroblasts is dependent on the nuclear vitamin D receptor. Carcinogenesis 1996; 17: 1389-91.
129. Birge SJ, Haddad JG. 25 hydroxy cholecalciferol stimulatin of muscle metabolism. J Clin Invest 1975; 560: 1100-7.
130. Vu D, Ong JM, Clemens TL, Kern PA. 1,25-Dihydroxyvitamin D induces lipoprotein lipase expression in 3T3-L1 cells in association with adipocyte differentiation. Endocrinology 1996; 137: 1540-4.
131. Lal H, Marya RK, Saini AS Effect of vitamin D on hepatic cellular growth in the rat. Nutr Res 1986; 6: 809-13.
132. Marya RK, Lal H, Chugh K, Saini AS. Effect of vitamin D administration during pregnancy on neonatal growth in the rat. Ann Nutr Metab 1989; 33: 261-5.
133. Marya RK, Rathee S, Dua V, Sangwan K. Effect of vitamin D supplementation during pregnancy on foetal growth. Indian J Med Res 1988; 88: 488-92.
134. Marya RK, Saini AS, Lal H, Chugh K. Effect of vitamin D supplementation in lactating rats on the neonatal growth. Indian J Physiol Pharmacol 1991; 35: 170-4.
135. Kalkwarf HJ, Specker BL, Heibi JE, Vieira NE, Yergey AL. Intestinal calcium absorption of women during lactation and after weaning. Am J Clin Nutr 1996; 63: 526-31.
136. Marya RK, Saini AS, Lal H, Chugh K. Role of vitamin D in perinatal growth in the rat. Nutr Res 1991; 11: 765-70.
137. Kaur J, Marya RK, Rathee S, Lal H, Singh GP. Effect of pharmacological doses of vitamin D during pregnancy on placental protein status and birth weight. Nutr Res 1991; 11: 1077-81.
138. 3 by human placenta in vitro. J Clin Endocrinol Metab 1981; 53: 484-8.
139. Richards SR, Kirn MH, Malarkey WB. Evidence that chorion-decidual prolactin release is calcium dependent. J Clin Endocrinol Metab 1982; 54: 820-3.
140. Delvin EE, Arabian A, Gilorieux FH, Mamer OA. In vitro metabolism of 25-hydroxycholecalciferol by isolated cells from human decidua. J Clin Endocrinol Metab 1985; 60: 880-5.
141. Mallet E, Gugi B, Henoeq RA, Basuyau JP, Lemeur H. Vitamin D supplementation in pregnancy: A controlled trial of two methods. Obstet Gynecol 1986; 68: 300-4.
142. Lal H, Chugh K. Metabolic and regulatory effects of branched chain amino acid supplementation. Nutr Res 1995; 15: 1717-33.
143. 3. Cancer Res 1987; 47: 21-5.
144. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res 1993; 53:3712-8.
145. 3 on proliferation and differentiation of Caco-2 cells. Endocrinology 1994; 134: 1710-7.
146. 3. Cancer Res 1994; 54: 4057-64.
147. Thomas MG, Tebbutt S, Williamson RCN. Vitamin D and its metabolites inhibit cell proliferation in human rectal mucosa and a colon cancer cell line. Gut 1992; 33: 1660-3.
148. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED. Serum 25-hydroxyvitamin D and colon cancer: Eight-year prospective study. Lancet 1989; II: 1176-8.
149. Boutron MC, Faivre J, Marteau P, Couillault C, Senesse P, Quipourt V. Calcium, phosphorus, vitamin D, dairy product and colorectal carcinogenesis: A French case-control study . Br J Cancer 1996; 74: 145-51.
150. Pence BC, Buddingh F. Inhibition of dietary fat-promoted colon carcinogenesis rats by supplemental calcium or vitamin D. Carcinogenesis 1988; 9: 187-190.
151. 3 in chemically induced rat colon carcinogenesis. Carcinogenesis 1992; 13: 2293-8.
152. Wali RK, Bissonnette M, Khare S, Aquino B, Niedriela S, Siutrin M, Brasitus TA. Protein kinase isoforms in the chemopreventive effects of a novel vitamin D analogue in rat colonie tumorigenesis. Gastroenterology 1996; 111: 118-26.
153. 2+-independent isoforms of protein kinase C in rat colonocytes. J Clin Invest 1995; 95: 2215-21.
154. Thomas MG, Nugent KP, Forbes A, Williamson RCN. Calcipotriol inhibits rectal epithelial cell proliferation in ulcerative proctocolitis. Gut 1994; 35: 1718-20.
155. 3 receptor measurement in primary renal cell carcinomas and autologous normal kidney tissue. Cancer Res 1988; 48: 2458-61.
156. 3 on the growth of the renal carcinoma cell line. Kidney Int 1986; 26: 834-40.
157. 3 increases the sensitivity of human renal carcinoma cells to tumor necrosis factor α but not to interferon α or lymphokine-activated killer cells. J Endocrinol 1996; 149: 327-33.
158. 3 on mouse peritoneal macrophage functions. J Immunol 1989; 143: 3686-90.
159. 3 potentiates the cytotoxic effect of TNF on human breast cancer cells. Mol Cell Endocrinol 1994; 106: 157-62.
160. 3 receptor in breast cancer. Cancer Res 1987; 47: 6793-9.
161. Colston KW, Berger U, Coombes RC. Possible role for vitamin D in controlling breast cancer cell proliferation. Lancet 1989; 1: 188-91.
162. 3 binding in estrogen-responsive rat breast tumor. Endocrinology 1986; 119: 397-403.
163. 3 receptors in T47D breast cancer cells. J Steroid Biochem Mol Biol 1993; 45: 257-63.
164. 3 inhibition of breast cancer cell proliferation. Endocrinology 1986; 119: 2284-9.
165. 3 in human breast cancer cells. Cancer Res 1988; 48: 2734-9.
166. Colston KW, MacKay AG, James SY, Binderup L, Chander S, Coombes RC EB1089: A new vitamin D analogue that inhibits the growth of breast cancer cells in vivo and in vitro. Biochem Pharmacol 1992; 44: 2273-80.
167. Colston KW, Chander SK, Mackay AG, Coombes RC. Effects of synthetic vitamin D analogues in breast cancer cell proliferation in vivo and in vitro. Biochem Pharmacol 1992; 44: 693-702.
168. Sorensen H, Binderoup L, Calverley MJ, Hoffmeyer L, Andersen NR. In vitro metabolism of calcipotriol (MC903), a vitamin D analogue. Biochem Pharmacol 1990; 39: 391-3.
169. Schwartz G, Hulka BS. Is vitamin D deficiency a risk factor for prostatic cancer? Anticancer Res 1990; 20: 1307-11.
170. Hanchette CL, Schwartz GG. Geographic patterns of prostate cancer mortality. Evidence for a protective effect of ultraviolet radiation. Cancer 1992; 70: 2861-9.
171. Esquenet M, Swinnen JV, Heyns W, Verhoeven G. Control of LNCaP proliferation and differentiation: Actions and interactions of androgens, 1,alpha,25-dihydrocholecalciferol, all-transretinoic acid, 9-cis retinoic acid, and phenylacetate. Prostate 1996; 28: 182-94.
172. Cohen P, Peehl DM, Lamson G, Rosenfeld RG. Insulin like growth factors (IGFs), IGF receptors, and IGF-binding proteins in primary cultures of prostate epithelial cells. J Clin Endocrinol Metab 1991; 73: 401-7.
173. Drivdahl RH, Loop SM, Andress DL, Ostenson RC. IGF-binding proteins in human prostate tumor cells: Expression and regulation by 1,25-dihydroxy-vitamin D. Prostate 1995; 26: 72-9.
174. 3 receptors and actions in human prostate cancer cell lines. Endocrinology 1993; 132: 1952-60
175. 3 on primary cultures of human prostatic cells. Cancer Res 1994; 54: 805-10.
176. 3 are mediated exclusively through the genomic signaling pathway. Endocrinology 1996; 137:1554-61.
177. Lasky SR, Iwata K, Rosmarin AG, Caprio DG, Maizel AL. Differentiaal regulation of JunD by dihydroxychqlecalciferol in human chronic myelogenous leukemia cells. J Biol Chem 1995; 270: 19676-9.
178. Brown TR, Stonehouse TJ, Branch JS, Brickell PM,Katz DR. Stable transfection of U937 cells with sense or antisense RXR-alpha cDNA suggests a role for RXR-alpha in the control of monoblastic differentiation induced by retinoic acid and vitamin D. Exp Cell Res 1997; 236: 94-102.
179. Hewison M, Dabrowski M, Vadher S, Faulkner L, Cockerill FJ, Brickell PM, O'Riordan JL, Katz DR. Antisense inhibition of vitamin D receptor expression induces apoptosis in monoblastoid U937 cells. J Immunol 1996; 156: 4391-400.
180. 3 analogue (KH 1060) with 9-cis-retinoic and irreversibly inhibits clonal growth, decreases bcl-2 expression and induces apoptosis in HL-60 leukemic cells. Cancer Res 1996;56:3570-6.
181. Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS. Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res 1997; 57: 3759-64.
182. Albert DM, Marcus DM, Gallo JP, O'Brien JM. The antineoplastic effect of vitamin D in transgenic mice with retinoblastoma. Invest Ophthalmol Vis Sci 1992; 33: 2354-64.
183. 3 analogues. Eur J Pharmacol 1990; 178: 247-50.
184. Kaiser U, Schilli M, Wegmann B, Barth P, Wadel S, Hofmann J, Havemann K. Expression of vitamin D receptor in lung cancer. J Cancer Res Clin Oncol 1996; 122: 356-9.
185. Frankel TL, Mason RS, Hersey P, Mirray E, Posen S. The synthesis of vitamin D metabolites by human melanoma cells. J Clin Endocrinol Metab 1983; 57: 627-31.
186. 3 and retinoic acid. Cancer Res 1985; 45: 1474-8.
187. Tomita Y, Fukushumia O, Tagami H. Stimulation of melanogenesis by cholecalciferol in cultural human melanocytes; a possible mechanism underlying pigmentation after ultraviolet irradiation. J Exp Med 1986; 149: 451-2.
188. Mawr CP, Gordon PR, Ray S, Holick MF, Gilchrest BA. Vitamin D, its precursors and metabolites do not affect melanization of cultural human melanocytes. J Invest Dermatol 1988; 91: 16-21.
189. 3 production by human keratinocytes. Kinetics and regulation. J Clin Invest 1986; 78: 557-66.
190. Bikle DD, Pillai S. Vitamin D, calcium and epidermal differentiation. Endocr Rev 1993; 14: 3-19.
191. 3-report of two cases. J Dermatol 1987; 14: 59-62.
192. 3, MC903, and their analogues herald a new pharamacologic era for the treatment of psoariasis? (Editorial). Arch Dermatol 1989; 125: 1692-7.
193. 3 treatment in psoriasis vulgaris. Br J Dermatol 1986; 115: 421-9.
194. Kragballe K. Treatment of psoriasis by the topical application of the novel cholecalciferol analogue calcipotriol (MC903). Arch Dermatol 1989; 125: 1647-52.
195. 3 in human skin in vivo. J Invest Dermatol 1997; 108: 513-8.